Altace, Ramipril News

ADDRESS: Franz H. Messerli, MD, Division of Cardiology, St. Luke's Roosevelt Hospital Center, 1000 10th Avenue, Suite 3B-30, New York, NY 10019; e-mail FMesserli{at}aol.com . MELANA YUZEFPOLSKAYA , MD A: No.

From the Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland , Dublin, Ireland; Division of Cardiovascular Diseases, Western Pennsylvania Hospital , Pittsburgh, Pa; Department of Nephrology and Hypertension, University of Erlangen-Nrnberg , Erlangen, Germany; Department of Medicine, Centre Hospitalier Universitaire Vaudois , ...

Effective Jan. 1, UTU members taking certain brand-name drugs will be required to pay more for them unless they switch to generic or preferred versions.

Paolo Verdecchia, MD ; Peter Sleight, MD ; Giuseppe Mancia, MD ; Robert Fagard, MD, PhD ; Bruno Trimarco, MD ; Roland E. Schmieder, MD ; Jae-Hyung Kim, MD ; Garry Jennings, MBBS, PhD ; Petr Jansky, MD ; Jyh-Hong Chen, MD ; Lisheng Liu, MD ; Peggy Gao, MSc ; Jeffrey Probstfield, MD ; Koon Teo, MD ; Salim Yusuf, MD, DPhil, FRCPC , for the ...

I have just started losartan potassium with side effects of dizziness, lightheadedness.

From the Hospital S. Maria della Misericordia, Clinical Research Unit Preventive Cardiology, Perugia, Italy ; Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada ; Cardiovascular Medicine, John Radcliffe Hospital, Oxford, UK ; University of Milano-Bicocca, Milano, Italy ; Hypertension Unit, Catholic University of ...

A particular class of medication used to treat high blood pressure could protect older adults against memory decline and other impairments in cognitive function, according to a newly published study from Wake Forest University School of Medicine.

From the Bioengineering and Chronobiology Laboratories, University of Vigo, Campus Universitario, Vigo, 36200 Spain.

By MARLEY SEAMAN Watson Pharmaceuticals Inc. said Wednesday it will buy smaller generic drug maker Arrow Group for $1.75 billion in cash and stock, getting access to a promising drug candidate pipeline and new markets.Watson of Morristown, N.J., said the combined company will have about $3 billion in annual revenue and do business in more than 20 ...

Wouldn't it be great if one pill could cure everything? While a pill to cure every illness known to man is still in the planning stages, a pill that could prevent a wide variety of chronic illnesses has been researched and is showing some promise.

Clinical studies have demonstrated a different effect on blood pressure of some angiotensin-converting enzyme inhibitors when administered in the morning versus the evening.